Does U= U for breastfeeding mothers and infants? Breastfeeding by mothers on effective treatment for HIV infection in high-income settings

C Waitt, N Low, P Van de Perre, F Lyons, M Loutfy… - The Lancet …, 2018 - thelancet.com
Summary Can the campaign Undetectable= Untransmittable (U= U), established for the
sexual transmission of HIV, be applied to the transmission of HIV through breastfeeding …

Transmission of CMV, HTLV-1, and HIV through breastmilk

AJ Prendergast, AE Goga, C Waitt… - The Lancet Child & …, 2019 - thelancet.com
Breastfeeding is a crucial child survival intervention. However, the potential for transmission
of viral infections from mother to child presents the dilemma of how best to interpret the …

Characterization of nanodiamond-based anti-HIV drug delivery to the brain

U Roy, V Drozd, A Durygin, J Rodriguez, P Barber… - Scientific reports, 2018 - nature.com
Abstract Human Immunodeficiency Virus Type 1 (HIV-1) remains one of the leading causes
of death worldwide. Present combination antiretroviral therapy has substantially improved …

Optimizing pharmacology studies in pregnant and lactating women using lessons from HIV: a consensus statement

AC Eke, A Olagunju, J Momper… - Clinical …, 2021 - Wiley Online Library
Information on the extent of drug exposure to mothers and infants during pregnancy and
lactation normally becomes available years after regulatory approval of a drug. Clinicians …

[HTML][HTML] African Pharmacogenomics Consortium: consolidating pharmacogenomics knowledge, capacity development and translation in Africa: consolidating …

C Dandara, C Masimirembwa, YZ Haffani… - AAS Open …, 2019 - ncbi.nlm.nih.gov
Abstract The African Pharmacogenomics Consortium (APC) was formally launched on the
6th September 2018. This white paper outlines its vision, and objectives towards addressing …

A systematic review on maternal-to-infant transfer of drugs through breast milk during the treatment of malaria, tuberculosis, and neglected tropical diseases

FW Ojara, AN Kawuma, C Waitt - PLOS Neglected Tropical …, 2023 - journals.plos.org
Background Exclusive breastfeeding of infants under 6 months of age is recommended by
the World Health Organization. In 2021, over 300 million combined incident cases of …

Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother–infant pairs

C Waitt, A Olagunju, S Nakalema… - Journal of …, 2018 - academic.oup.com
Background Breast milk transfer of first-line ART from mother to infant is not fully understood.
Objectives To determine the concentrations of lamivudine, emtricitabine and tenofovir in …

Physiologically based pharmacokinetic modeling to determine the impact of CYP2B6 genotype on efavirenz exposure in children, mothers and breastfeeding infants

X Pan, K Rowland Yeo - Clinical Pharmacology & Therapeutics, 2023 - Wiley Online Library
The antiretroviral drug efavirenz remains widely used in children and mothers during
breastfeeding in tuberculosis‐endemic areas. Evaluating the safety of efavirenz during …

Distribution evaluation of tenofovir in the breast milk of mothers with HBeAg-positive chronic HBV infection after treatment with tenofovir alafenamide and tenofovir …

N Yang, G Zhou, X Cheng, J He, Y Chen… - Frontiers in …, 2021 - frontiersin.org
Tenofovir alafenamide (TAF) is a novel prodrug of tenofovir (TFV) that has been approved
for the treatment of chronic hepatitis B virus (HBV) infection. It has greater plasma stability …

Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria

JN Nwogu, M Gandhi, A Owen, SH Khoo, B Taiwo… - Aids, 2021 - journals.lww.com
Objective: Efavirenz (EFV) use is associated with neuropsychiatric side effects, which may
include poor neurocognitive performance. We evaluated single nucleotide polymorphisms in …